Topiramate Tablet, Film Coated
Product Images NDC 72789-443

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72789-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789443 Label (72789443)

72789443 Label (72789443)
This is a description for a medication containing Topiramate in 50 mg tablets. The package includes 60 tablets with an expiration date of 01/2026. It is important to keep the medication out of the reach of children and follow the dosage instructions provided in the package insert. Patients are advised to consult their doctor for medical advice regarding side effects and can report any side effects to the FDA. The tablets are light yellow, circular in shape, and each tablet is film-coated. Additionally, the medication comes with a Medication guide for patients, available online.*
FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)
This is a cumulative rates chart showing the time to the first seizure for patients taking Topiramate at different doses. The chart includes data for two groups: one group taking 50 mg/day and the other group taking 400 mg/day of Topiramate. The X-axis represents time in days while the Y-axis shows cumulative rates.*
FDA Label Image

Figure 2 (Topiramate Fig2)

Figure 2 (Topiramate Fig2)
This is a statistical analysis of the effectiveness of different doses of Topiramate and placebo on study participants over a certain period. The text mentions the dosages of Topiramate as 50mg/day, 100mg/day, and 200mg/day, with corresponding group sizes. It also indicates results in terms of change from baseline to the double-blind phase, with significance levels noted for statistical interpretation.*
FDA Label Image

Chemical Structure (Topiramate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.